Rfv3 is a host resistance gene that operates through an unknown mechanism to control the development of the virus-neutralizing antibody response required for recovery from infection with Friend retrovirus. The Rfv3 gene was previously mapped to an approximately 20-centimorgan (cM) region of chromosome 15. More refined mapping was not possible, due to a lack of microsatellite markers and leakiness in the Rfv3 phenotype, which prevented definitive phenotyping of individual recombinant mice. In the present study, we overcame these difficulties by taking advantage of seven new microsatellite markers in the Rfv3 region and by using progeny tests to accurately determine the Rfv3 phenotype of recombinant mice. Detailed linkage analysis of relevant crossovers narrowed the location of Rfv3 to a 0.83-cM region. Mapping of closely linked genes in an interspecific backcross panel allowed us to exclude two previous candidate genes, Ly6 and Wnt7b. These studies also showed for the first time that the Hsf1 gene maps to the Rfv3-linked cluster of genes including Il2rb, Il3rb, and Pdgfb. This localization of Rfv3 to a region of less than 1 cM now makes it feasible to attempt the cloning of Rfv3 by physical methods.
Infection with Friend virus complex (FV) induces rapid polyclonal erythroid cell proliferation and splenomegaly in genetically susceptible adult mice (5, 10) . Mice of strains which mount rapid humoral and cell-mediated FV-specific immune responses spontaneously recover from FV-induced splenomegaly without progressing to erythroleukemia. Such recovery from FV disease is dependent on a number of host genes, including several genes of the major histocompatibility complex (MHC), which influence critical CD4 ϩ -and CD8
ϩ -T-cell responses (5, 13) . However, unlike some other viral systems in which either a cellular or humoral immune response alone is sufficient to resolve infection (1, 19, 20) , spontaneous recovery from FV requires both FV-specific T-cell responses and virusneutralizing antibody responses (6, 12, 21) .
The non-MHC gene Rfv3 influences the ability of mice to mount FV-neutralizing antibody responses following infection (6) (6, 7, 9) . At about 2 weeks postinfection, mice carrying at least one dominant Rfv3 resistance allele (Rfv3 r ), such as (C57BL/10 ϫ A.BY)F 1 mice, begin to make FV-neutralizing antibodies, and they usually clear FV plasma viremia by 30 days postinfection (DPI). In contrast, mice with two sensitive alleles (Rfv3 s /Rfv3 s ) fail to make FV-neutralizing antibodies, remain viremic, and eventually succumb to FVinduced erythroleukemic splenomegaly (6, 9) . Interestingly, Rfv3 s /Rfv3 s mice have normal antibody responses to other antigens, suggesting that these mice are not generally immunosuppressed (18) . The mechanism whereby Rfv3 controls the FV-specific humoral response remains unknown. The gene has been mapped to a 20-centimorgan (cM) region of mouse chromosome 15, ruling out linkage to genes such as MHC genes, immunoglobulin genes, or T-cell receptor genes (14) . In this study, we used progeny testing and microsatellite linkage analysis with seven new markers to define the location of the Rfv3 gene to a region of less than 1 cM. These experiments determined that the previous candidate genes, Ly6 and Wnt7, mapped to regions adjacent to, rather than within, the Rfv3 gene region.
To map the Rfv3 gene, heterozygous (B10.A ϫ A/Wy)F 1 mice (Rfv3 r /Rfv3 s ) were intercrossed to produce F 2 offspring. Tail tip DNA samples from 181 F 2 mice were analyzed by using PCR amplification of simple sequence length polymorphisms (microsatellites) (15) . Initially, two markers, D15Mit28 and D15Mit108, which flank the 20-cM region containing the Rfv3 gene (14) , were used to identify 45 recombinant F 2 mice. DNA from these recombinants with microsatellite markers lying between the flanking markers was further tested, and nine recombination locations (groups I through IX) were identified ( Fig. 1) . Because the Rfv3 phenotype shows some leakiness even in genetically identical mice ( Fig. 1 ) (14), we could not rely on the accuracy of phenotyping of individual recombinant F 2 mice. Rather, the recombinant F 2 mice were backcrossed to A/Wy parental mice, and the resulting progeny were genotyped and tested. A total of 23 of the 45 recombinant F 2 mice were backcrossed, and all progeny were genotyped prior to phenotypic analysis. For determination of the Rfv3 phenotype, recombinant progeny and a number of nonrecombinant littermate control mice were infected with FV and tested for plasma viremia at 30 DPI. Viremia has been shown to inversely correlate with FV-neutralizing antibody production (9, 22) and is a convenient assay for determining the Rfv3 phenotype. Mice exhibiting less than 200 focus-forming units (FFU)/ml of plasma were scored as nonviremic, whereas mice with more than 10 4 FFU/ml of plasma were considered highly viremic. Leakiness in the Rfv3 phenotype was manifested by intermediate viremia levels, which were observed at a low incidence in both Rfv3 r /Rfv3 s and Rfv3 s /Rfv3 s controls (Fig. 1) .
To map Rfv3, we looked for a correlation between the genotypes and phenotypes in the recombinant backcross progeny. High levels of viremia were seen in 35 of 46 (76%) recombinant progeny from groups I, II, III, IV, and V. When the genotypes of these mice were compared, it was observed that the mice had the Rfv3 s /Rfv3 s genotype at marker D15Mit214 (Fig. 1) . In contrast, the low-viremia groups VI, VII, and VIII had the Rfv3 r /Rfv3 s genotype at this marker (Fig. 1) . These results indicated that the Rfv3 gene was located near D15Mit214 in a region between markers D15Mit70 and D15Mit107.
Group IX, which consisted of progeny from three F 2 recombinants, R45, R172, and R80, exhibited both high and low levels of viremia ( Fig. 1 and 2 ). This variability prompted further typing of the mice of this group in order to detect possible differences in recombination positions. Typing with three markers located between D15Mit214 and D15Mit107 revealed unique crossover positions in these three recombinants (Fig. 2) . Interestingly, 17 of 18 progeny of R45 were either nonviremic or showed only intermediate viremia (Ͻ10 4 FFU/ml of plasma), whereas 20 of 21 progeny of recombinants R172 and R80 were highly viremic (Fig. 2) . These data were consistent with a location for Rfv3 that was distal to D15Mit239 and proximal to D15Mit107 (Fig. 2) . Progeny testing of another recombinant mouse, R8 (group III), with a recombination in the same region supported this position for Rfv3 (Fig. 2) .
The genotyping of recombinant F 2 mice has allowed us to determine the genetic distances between the D15Mit markers used in this study. Our previous results indicated that Rfv3 was located in a 5-to 20-cM region between D15Mit108 and D15Mit93. Here, we genotyped F 2 mice with the microsatellite markers D15Mit108 and D15Mit28, which is very closely linked to D15Mit93. We now estimate the distance between these markers to be 12.2 cM (Fig. 3A) . Furthermore, our mapping of Rfv3 between D15Mit239 and D15Mit107 localizes the Rfv3 position to a 0.83-cM region of chromosome 15 (Fig. 3A) .
To identify other genes in the interval of the Rfv3 locus, we mapped two closely linked markers, D15Mit214 and D15Mit239, in an interspecific backcross panel derived from the matings of (C57BL/6J ϫ Mus spretus)F 1 ϫ C57BL/6J mice (8) . This mapping panel has been typed for over 2,700 loci, most of which are genes that are well distributed among all the autosomes as well as the X chromosome. By this analysis, Rfv3 was separable from Ly6 and Wnt7b (Fig. 3B) , two genes which cosegregated with Rfv3 in previous experiments (14) . However, Rfv3 colocalized with a cluster of genes including the immunesystem-related genes Il2rb (interleukin 2 [IL-2] receptor beta), Il3rb1 (IL-3 receptor beta 1), and Pdgfb (platelet-derived growth factor beta) in the central region of mouse chromosome 15 (3, 4, 11) . This cluster of loci is 0.9 cM distal to Ly6 and 3.1 cM proximal to Wnt7b (Fig. 3B) .
One previously unmapped gene, Hsf1 (heat shock factor 1), was also found to map to the same gene region as Rfv3. The position of Hsf1 was determined by Southern blot analysis with a cDNA probe (16) . Major fragments of 11.5 and 2.8 kb were detected in TaqI-digested C57BL/6J DNA, and major fragments of 5.2 and 3.1 kb were detected in TaqI-digested M. spretus DNA. The presence or absence of the M. spretus fragments which cosegregated was monitored in [(C57BL/6 ϫ M. spretus) ϫ C57BL/6]B 1 backcross mice. Recombination distances were calculated with Map Manager, version 2.6.5, and the gene order was determined by minimizing the number of recombination events required to explain the allele distribution patterns.
Ideally, it would be desirable to type the critical recombinant mice for crossovers between Rfv3 and the candidate genes Il2rb, Il3rb1, Pdgfb, and Hsf1. However, to our knowledge, no polymorphisms that distinguish the alleles of these genes in the C57BL/10 and A/Wy strains of mice have been reported. Furthermore, no crossovers between any of these genes have been detected in several crosses including Mus musculus and M. spretus, where distinguishing between alleles is more feasible. Because of the obvious importance of IL-2 receptor-mediated signal transduction in many immune responses, we made a preliminary attempt to detect allele-specific polymorphisms in Il2rb mRNAs but found no allelic differences between C57BL/ 10 and A/Wy mice. Also, we found no significant differences in the levels of expression of Il2rb when spleen RNA was examined by RNase protection assays at multiple time points during the first 3 weeks following infection with FV (data not shown).
The present study has narrowed the location of Rfv3 by a factor of over 20 and has both excluded two previous candidate genes and included Hsf1 as a new candidate. The central region of mouse chromosome 15 has homology with human chromosomes 8q and 22q (Fig. 3B) , and further mapping of these regions of the human chromosomes may uncover additional candidate genes. While the analysis of candidates is appealing, the Rfv3 gene region could contain numerous unidentified genes, any of which could be Rfv3. The real advantage of the current fine mapping is that identification of Rfv3 by physical means is now feasible. Bacterial artificial chromosomes containing overlapping sections of the Rfv3 region can be produced and used to breed transgenic mice. The future identification of the Rfv3 gene will aid our understanding of the control of the FV host immune response and may ultimately contribute more generally to understanding human retroviral immunity.
